Marketing Molecular Biology Small Molecule Workshop 
Drug Discovery World
FEBRUARY 27, 2023
DDW’s Diana Spencer speaks to Raphael Townshend PhD, Founder and CEO of Atomic AI, about the company’s successes so far, plans for the future and the unique approach of combining RNA structural biology and AI models. What advice do you have for other start-ups hoping to launch into this market?
Drug Discovery World
NOVEMBER 15, 2022
As such, the synthesis of DNA oligonucleotides for routine molecular biology applications is often outsourced to service provider companies that operate DNA synthesisers to meet these demands. . By 2027, the synthetic biology market across all industries, drug discovery included, is expected to reach US $32.9
Expert insights. Personalized for you.
130 
Let's personalize your content